A carregar...
Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability
Perampanel (PER) is a novel antiepileptic drug recently introduced for the adjunctive treatment in epilepsy patients aged 12 years or older with partial-onset seizures with or without secondary generalization in the US and Europe. Its antiepileptic action is based on noncompetitive inhibition of pos...
Na minha lista:
| Publicado no: | Patient Prefer Adherence |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4542413/ https://ncbi.nlm.nih.gov/pubmed/26316718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S63951 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|